SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-18-002918
Filing Date
2018-11-02
Accepted
2018-11-02 17:15:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d12042002_11012018.htm SC 13D 182263
2 JOINT FILING AGREEMENT ex991to13d12042002_110118.htm EX-99.1 10391
  Complete submission text file 0000921895-18-002918.txt   194149
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86778 | Film No.: 181158045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734
Business Address 2110 RANCH ROAD 620 S 341732 LAKEWAY TX 78734 5127614500
JFL Capital Management, LLC (Filed by) CIK: 0001687888 (see all company filings)

IRS No.: 472302073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D